Published in Prostaglandins on June 01, 1990
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol (2004) 2.18
13C-urea versus 14C-urea breath test: is there still a need for 14C-urea? Nucl Med Commun (1998) 2.06
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
Motivational aspects of deliberate self-poisoning in adolescents. Br J Psychiatry (1982) 1.62
Adolescents who take overdoses: their characteristics, problems and contacts with helping agencies. Br J Psychiatry (1982) 1.59
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol (1982) 1.48
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. Am J Hematol (1991) 1.43
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man. Eur J Cardiol (1980) 1.36
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Stenoses of vascular anastomoses after hepatic transplantation: treatment with balloon angioplasty. AJR Am J Roentgenol (1991) 1.34
Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts. J Eukaryot Microbiol (2000) 1.32
Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon? Prostaglandins (1981) 1.31
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE) Eur J Nucl Med (1998) 1.25
Labelling of platelets with indium-111 oxine and technetium-99m hexamethylpropylene amine oxime: suggested methods. International Society of Radiolabelled Blood Elements (ISORBE). Eur J Nucl Med (1999) 1.18
Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation (1994) 1.11
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut (2007) 1.11
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Fam Pract (2001) 1.11
Aspirin: A paradoxical effect on bleeding-time. Lancet (1978) 1.08
Hyperacute rejection in liver transplantation: a case report. Transplant Proc (1989) 1.07
Prevalence and relevance of thyroid dysfunction in 1922 cholesterol screening participants. J Clin Epidemiol (2000) 1.07
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Decreased vascular prostacyclin in juvenile-onset diabetes. N Engl J Med (1979) 1.06
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am J Trop Med Hyg (2004) 1.05
A modified larval migration assay for detection of resistance to macrocyclic lactones in Haemonchus contortus, and drug screening with Trichostrongylidae parasites. Vet Parasitol (2006) 1.04
Prostacyclin generation in atherosclerotic arteries. Lancet (1979) 1.04
Passive smoking and cardiovascular risk. Arch Intern Med (1995) 1.03
A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials. Eur J Nucl Med (1984) 1.00
Effects of fenofibrate on endothelial function and cell adhesion molecules during post-prandial lipemia in hypertriglyceridemia. J Clin Pharm Ther (2003) 1.00
Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Trop Med Int Health (2012) 0.99
Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit. J Hosp Infect (1991) 0.99
Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. Br Med J (1980) 0.99
Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol (1992) 0.98
Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest (1986) 0.98
Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol (1982) 0.98
Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. J Cardiovasc Pharmacol (2000) 0.98
Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovasc Res (2000) 0.97
Nitric oxide synthesis is increased in periodontal disease. J Periodontal Res (1998) 0.97
Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol (2002) 0.97
Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis (1999) 0.97
Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology (1992) 0.97
Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience (2005) 0.95
Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95
Organisation of experimental thrombosis by blood cells. Evidence of the transformation of mononuclear cells into myofibroblasts and endothelial cells. Virchows Arch A Pathol Anat Histopathol (1985) 0.95
Quantitative investigation of sudanophilic lesions around the aortic ostia of human fetuses, newborn and children. Blood Vessels (1980) 0.95
Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc (1989) 0.95
Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology (1993) 0.93
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res (2000) 0.93
Genetic variation in DNMT3B and increased global DNA methylation is associated with suicide attempts in psychiatric patients. Genes Brain Behav (2012) 0.93
Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation? Atherosclerosis (2000) 0.92
Reduced umbilical artery prostacyclin formation in complicated pregnancies. Am J Obstet Gynecol (1982) 0.92
Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. Wien Klin Wochenschr (1999) 0.92
Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines. J Nucl Med (2000) 0.92
Diminished prostacyclin formation in umbilical arteries of babies born to women who smoke. Lancet (1981) 0.92
Liver transplantation in adults coinfected with HIV. Transplantation (2001) 0.91
Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet (1982) 0.91
A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man. Br J Clin Pharmacol (1984) 0.91
Exploring the anthelmintic properties of Australian native shrubs with respect to their potential role in livestock grazing systems. Parasitology (2009) 0.91
Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res (2000) 0.90
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med (1991) 0.90
Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology (1986) 0.90
Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery. Clin Radiol (2002) 0.89
Do human platelets express COX-2? Prostaglandins Leukot Essent Fatty Acids (2001) 0.89
Clinical pharmacology in the pharmaceutical industry. Br J Clin Pharmacol (1991) 0.89
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut (2006) 0.89
Influence of radiation synovectomy on articular cartilage, synovial thickness and enhancement as evidenced by MRI in patients with chronic synovitis. J Nucl Med (1999) 0.89
Imaging of human atherosclerotic lesions using 123I-low-density lipoprotein. Eur J Nucl Med (1986) 0.89
Low cholesterol and cancer. J Clin Oncol (1996) 0.89
Tuberculosis in prisons: anatomy of global neglect. Eur Respir J (2011) 0.89
Epoprostenol and platelet deposition in atherosclerosis. Lancet (1984) 0.88
Sensitivity of platelets to prostaglandins in cornary heart disease and angina pectoris. Prostaglandins (1981) 0.88
Increase of isoprostane 8-epi-PGF(2alpha)after restarting smoking. Prostaglandins Leukot Essent Fatty Acids (2001) 0.87
Implanted vascular prostheses generate prostacyclin. Lancet (1978) 0.87
[Diclofenac and platelet aggregation]. Wien Med Wochenschr (1977) 0.87
The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1982) 0.87
Decrease of prostaglandin I2 binding sites in thyroid cancer. Br J Cancer (1988) 0.87
The cyclo-oxygenase and lipoxygenase pathways in human oral cancer tissue. J Maxillofac Surg (1984) 0.87
Hyperalphalipoproteinemia and prostaglandin I2 stability. Thromb Res (1997) 0.87